Julio Castro Gayol
Addiction Psychiatry · Palmetto Bay, FLNPI 1083871784
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 2 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Neurocrine Biosciences, Inc. accounts for 80.9% of it on its own, with 1 other manufacturer making up the rest. That places this record below the midpoint for addiction psychiatry clinicians in FL, where the typical reported total is $237.
Across 2 payments — averaging $49.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurocrine Biosciences, Inc.$80
- Astellas Pharma US Inc$19
Across 82 payments — averaging $5388.16 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Neurocrine Biosciences, Inc.$321K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$51K
- Biohaven Pharmaceuticals, Inc.$29K
- Boehringer Ingelheim$15K
- AbbVie$14K
- Biohaven Pharmaceutical Holding Company Ltd.$10K
- plus $3K from 1 others
What the payments were for
- Food & beverage$99100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neurocrine Biosciences, Inc. | 1 | $80 |
| Astellas Pharma US Inc | 1 | $19 |
How this compares
$99 in reported general payments places this provider in the 30th percentile of 29 addiction psychiatry providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trazodone Hcl | 2,529 | $9,474 |
| Quetiapine Fumarate | 3,876 | $8,624 |
| Buspirone Hcl | 2,098 | $7,241 |
| Sertraline Hcl | 1,843 | $5,827 |
| Bupropion Hcl SrBupropion Hcl | 461 | $5,531 |
| Duloxetine Hcl | 1,081 | $5,348 |
| Divalproex Sodium | 620 | $4,534 |
| Mirtazapine | 1,753 | $4,225 |
| Trifluoperazine Hcl | 101 | $3,674 |
| Escitalopram Oxalate | 1,162 | $3,373 |
| Clonazepam | 1,173 | $2,472 |
| Doxepin Hcl | 330 | $2,042 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 253 | $1,955 |
| Olanzapine | 349 | $1,508 |
| Temazepam | 601 | $1,286 |
Paid to pharmacies, not to this prescriber.
Other addiction psychiatry in Palmetto Bay
- Raul RodriguezDelray Beach$31K
- Jason FieldsNew Port Richey$26K
- Edward BariasJupiter$21K
- Mary SheehanTampa$16K
- Aldo MoralesFort Lauderdale$13K
- Krishan BatraOdessa$10K
- Lawrence WeinsteinSt Petersburg$6K
- Syed ZaidiPinellas Park$5K
- Vincence DillonPensacola$2K
- Curtis PhillipsDelray Beach$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.